ESC Premium Access

Direct oral anticoagulant rivaroxaban in very old and frail patients: A one-year prospective follow-up of a large-scale cohort (SAFIR-AC)


About the speaker

Doctor Olivier Hanon

Hospital Broca of Paris, Paris (France)
0 follower

3 more presentations in this session

Blood pressure and white matter lesions in patients with atrial fibrillation

Speaker: Professor D. Conen (Hamilton, CA)


Impact of AF type on the outcome of atrial fibrillation ablation: insights from the CABANA trial

Speaker: Assistant Professor K. Monahan (Rochester, US)


Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study

Speaker: Professor L. Fauchier (Tours, FR)


Access the full session

Atrial fibrillation: from drugs to ablation

Speakers: Doctor O. Hanon, Professor D. Conen, Assistant Professor K. Monahan, Professor L. Fauchier

About the event



31 August - 4 September 2019

Sessions Presentations

Related content

ESC Premium Access

APAF-CRT - Panel discussion.

28 August 2021

ESC Premium Access

APAF-CRT: AV junction ablation and CRT in patients with permanent atrial fibrillation and narrow QRS

28 August 2021

ESC Premium Access

Syncope as the initial manifestation of advanced nasopharyngeal carcinoma: a case report.

27 August 2021

This platform is supported by

logo Novo Nordisk